Thompson Kimberly Kraig's Form 4 filing
Kraig Biocraft Laboratories, Inc. (KBLB) · filed Jul 13, 2021
- Accession no.
- 0001493152-21-016684
- Filed
- Jul 13, 2021
- Trade date
- Jul 9, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Kimberly KraigCIK 0001837586 | Director, Officer (CEO & CFO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2021 | Common Stock | SSaleDisposed | −120,000 | –F1 | – | 203,749,547 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
120,000 shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on July 9, 2021 at a price of $0.1184 per share.
Referenced by the price of 1 transaction in Table I.